Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8, BD Move Closer to Rapid Bacterial Dx Development Agreement

NEW YORK (GenomeWeb News) – Accelr8 Technology said today that it has reached an agreement in principle with Becton Dickinson to fund an 18-month milestone project for Accelr8’s rapid bacterial diagnostic system.
 
Under terms of the preliminary pact, BD will receive an option to license the resulting technology to develop and sell a clinical diagnostic system for infectious diseases.
 
Last December, BD agreed to pay $100,000 for the right to negotiate the development agreement through yesterday. Accelr8 said at the time that the deal could include licensing rights, an equity investment, a joint development, or other type of development program.  
 
Accelr8 said today it expects the new agreement to be solidified by April 30.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.